Fingerprint
Dive into the research topics of 'Early response as a predictor of long-term clinical response in DMARD-naive patients with severe, active and progressive rheumatoid arthritis treated with certolizumab pegol plus optimized MTX versus optimized MTX alone'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically